Phenotyping Sciences provides Cancer Center faculty with diverse tools, techniques and expertise for the conduct of gene expression, molecular biology, flow cytometry, and protein chemistry methods. Created as a result of the reorganization of Scientific Services in 2004, this department comprises the former Microchemistry and Flow Cytometry Services. Microchemistry has been supported by the Cancer Center Support Grant since the Service was developed 17 years ago, while Flow Cytometry has been supported for the full 23-year term of the grant. The Phenotyping Sciences Service provides researchers with access to state-of-the-art gene expression technologies, nucleic acid isolation and quality assessment, gene targeting and transgenic construct design, protein chemistry services, advanced flow cytometric technology and a monoclonal antibody resource. Access to these services is essential to Cancer Center staff. Overall use of the Phenotyping Sciences Service has increased by 55% over the past five years. The Phenotyping Sciences Project Leader, Senior Staff Scientist Dr. Derry Roopenian, oversees this fee-for-service operation. Three gene expression technologists, two flow cytometrists, three molecular biologists, a protein chemist, and senior manager staff the facility which occupies 1,851 ft2 of laboratory space in the Research Laboratory Unit 4 building. The Service is dynamic, continuously increasing and improving its array of services to meet the needs of the Cancer Center members. Since the last renewal, significant advancements in technology have provided for the expansion and improvement of multi-color flow cytometry and sorting, gene expression microarray analysis, and multiplexed protein assay services. Phenotyping Sciences is completely integrated with the other services at the Center, including Computational Sciences, Reproductive Sciences-Cell Biology and Microinjection, and SNP Genotyping to provide a comprehensive set of support services for cancer research. Dr. Roopenian communicates with the Cancer Center users, Service staff and Center Administration to ensure that research needs are met in the most efficient, cost-effective and technically current manner.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
3P30CA034196-28S2
Application #
8476492
Study Section
Subcommittee G - Education (NCI)
Project Start
1997-08-01
Project End
2013-06-30
Budget Start
2012-08-03
Budget End
2013-06-30
Support Year
28
Fiscal Year
2012
Total Cost
$500,925
Indirect Cost
$214,682
Name
Jackson Laboratory
Department
Type
DUNS #
042140483
City
Bar Harbor
State
ME
Country
United States
Zip Code
04609
Jung, Seung-Hyun; Kim, Min Sung; Lee, Sung-Hak et al. (2016) Whole-exome sequencing identifies recurrent AKT1 mutations in sclerosing hemangioma of lung. Proc Natl Acad Sci U S A 113:10672-7
Qin, Wenning; Kutny, Peter M; Maser, Richard S et al. (2016) Generating Mouse Models Using CRISPR-Cas9-Mediated Genome Editing. Curr Protoc Mouse Biol 6:39-66
Tai, Derek J C; Ragavendran, Ashok; Manavalan, Poornima et al. (2016) Engineering microdeletions and microduplications by targeting segmental duplications with CRISPR. Nat Neurosci 19:517-22
Sundberg, John P; Pratt, C Herbert; Silva, Kathleen A et al. (2016) Dermal lymphatic dilation in a mouse model of alopecia areata. Exp Mol Pathol 100:332-6
Parvanov, Emil D; Tian, Hui; Billings, Timothy et al. (2016) PRDM9 interactions with other proteins provide a link between recombination hotspots and the chromosomal axis in meiosis. Mol Biol Cell :
Ali, Riyasat; Babad, Jeffrey; Follenzi, Antonia et al. (2016) Genetically modified human CD4(+) T cells can be evaluated in vivo without lethal graft-versus-host disease. Immunology 148:339-51
Ishimura, Ryuta; Nagy, Gabor; Dotu, Ivan et al. (2016) Activation of GCN2 kinase by ribosome stalling links translation elongation with translation initiation. Elife 5:
Jangalwe, Sonal; Shultz, Leonard D; Mathew, Anuja et al. (2016) Improved B cell development in humanized NOD-scid IL2Rγ(null) mice transgenically expressing human stem cell factor, granulocyte-macrophage colony-stimulating factor and interleukin-3. Immun Inflamm Dis 4:427-440
Samanta, S; Sun, H; Goel, H L et al. (2016) IMP3 promotes stem-like properties in triple-negative breast cancer by regulating SLUG. Oncogene 35:1111-21
Korstanje, Ron; Deutsch, Konstantin; Bolanos-Palmieri, Patricia et al. (2016) Loss of Kynurenine 3-Mono-oxygenase Causes Proteinuria. J Am Soc Nephrol 27:3271-3277

Showing the most recent 10 out of 958 publications